As part of the agreement, Endiatx will get access to Mayo Clinic clinicians and their knowledge. The company is developing robot pills that can be swallowed and move inside the stomach on their own, so providers can do upper endoscopies via a Zoom-like telemedicine platform.
“We were proud to give some equity to Mayo Clinic, and it means that we can co-develop this technology,” Endiatix CEO Torrey Smith told Medical Design & Outsourcing, noting that it’s a 15-year deal. “We’re not having them develop intellectual property, but what we are doing is having them coach us clinically. Basically, this is a chance to make sure that the tech that we are developing is exactly what gastroenterologists actually need.”
“The technology … marks the beginning of a new category in healthcare: microrobotics inside the human body,” Mr. Smith said in a Jan. 4 company news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
